---
schema_version: "secwatch.filing_event.v1"
accession: "0000914475-24-000140"
form_type: "8-K"
ticker: "NBIX"
cik: "0000914475"
company_name: "NEUROCRINE BIOSCIENCES INC"
filed_at: "2024-05-23T23:59:59+00:00"
generated_at: "2026-06-01T09:31:37.762945+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.2
calibrated_materiality_score: 0.2
confidence: "high"
source: SEC EDGAR
---

# Neurocrine stockholders elect directors, approve say-on-pay, amended equity plan, ratify EY

## Summary
- All four Class I directors elected: Rastetter, Morrow, Norwalk, Poon; each received >72M votes.
- Advisory say-on-pay passed with ~80.3M for vs 4.3M against.
- Amended 2020 Equity Incentive Plan approved (76.1M for, 9.5M against).
- Ernst & Young ratified as auditor for FY2024 with 84.6M for, 5.5M against.

## SEC filing metadata
- accession: 0000914475-24-000140
- form_type: 8-K
- ticker: NBIX
- cik: 0000914475
- company_name: NEUROCRINE BIOSCIENCES INC
- filed_at: 2024-05-23T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.2
- calibrated_materiality_score: 0.2
- confidence: high
- sec_items: 5.02, 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/914475/000091447524000140/0000914475-24-000140-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/914475/000091447524000140/nbix-20240522.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000914475-24-000140
- JSON: https://secwatch.observer/filing/0000914475-24-000140.json
- Plain text: https://secwatch.observer/filing/0000914475-24-000140.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.